Sarepta Therapeutics

EXONDYS-51

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Sarepta Therapeutics

Exondys-51 HCPCS:

J1428

HCPCS Code Descriptor:

Injection, eteplirsen, 10 mg

Category:

J Code

Exondys-51 NDCs:

60923-0363-02, 60923-0284-10

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Exondys-51 CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Exondys-51:

EXONDYS-51 is a Genetic Disorder drug manufactured by Sarepta Therapeutics and administered via the Intravenous route of administration. The J Code: J1428 is aligned to the drug EXONDYS-51.

ACCESS PRICING AND MORE BY REGISTERING

J1428 Added Date:

January 1, 2018

J1428 Effective Date:

January 1, 2018

J1428 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Exondys-51 billing and coding information.
Exondys-51 patient assistance information can be found through SareptAssist at the URL: https://www.exondys51.com/getting-support
EXONDYS-51 prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for EXONDYS-51. Please check back in a few weeks.